L'intérêt à découvert pour N-able donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de N-able. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

N-able (NYSE:NABL) Stock, Rapport sur les intérêts à découvert

N-ABLE INC

N-able

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

N-able Inc

<p>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) reported quarterly losses of $(0.14) per share. This is a 63.16 percent increase over losses of $(0.38) per share from the same period last year.  The company reported $11.30 million in sales this quarter.</p>


Earnings

News

IVVD

Invivyd Q1 EPS $(0.14) Up From $(0.38) YoY, Sales $11.30M Up from 0 YoY

<p><figure class="table"><br />
<table>
<tbody>
<tr>
<td colspan="6">Second quarter</td>
<td colspan="3">&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="6">The Company's second quarter fiscal 2026 guidance is based on Q2 FY25 net sales of $167.8 billion.</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">Consolidated metric</td>
<td colspan="3">Q2 FY26</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">Net sales (cc)</td>
<td colspan="3">
<p>Increase 3.5% to 4.5%</p>
<p>•Including approximately 20 bps tailwind from acquisition of VIZIO</p>
</td>
<td colspan="3">&nbsp;</td>
</tr>
</tbody>
</table>
<p></p></figure><figure class="table"><br />
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
<p></p></figure></p>


Guidance

Walmart Sees Q2 Sales $173.673B-$175.350B vs $175.21B Est

<p>Bragg Gaming Group (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BRAG#TSX">BRAG</a>) reported quarterly losses of $(0.11) per share. This is a 37.5 percent decrease over losses of $(0.08) per share from the same period last year.  The company reported $25.50 million in sales this quarter. This is a 7.11 percent increase over sales of $23.81 million the same period last year.</p>


TSX:BRAG

Bragg Gaming Group Q1 EPS Euros(0.11) Down From $(0.08) YoY, Sales Euros25.50M Up From Euros23.81M YoY

<p>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) reported quarterly losses of $(15.96) per share which missed the analyst consensus estimate of $(14.08) by 13.35 percent. This is a 13.64 percent increase over losses of $(18.48) per share from the same period last year.  The company reported quarterly sales of $13.64 million which missed the analyst consensus estimate of $13.99 million by 2.49 percent.  This is a 21.95 percent decrease over sales of $17.48 million the same period last year.</p>


Earnings Misses

VERO

Venus Concept Q1 Adj. EPS $(15.96) Misses $(14.08) Estimate, Sales $13.64M Miss $13.99M Estimate

<p>Bragg Gaming Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRAG#NASDAQ">BRAG</a>) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.01) by 1100 percent. This is a 33.33 percent decrease over losses of $(0.09) per share from the same period last year.  The company reported quarterly sales of $26.82 million which beat the analyst consensus estimate of $26.75 million by 0.28 percent.  This is a 3.72 percent increase over sales of $25.86 million the same period last year.</p>


Earnings Beats

BRAG

Bragg Gaming Group Q1 EPS $(0.12) Misses $(0.01) Estimate, Sales $26.82M Beat $26.75M Estimate

<p>Mersana Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRSN#NASDAQ">MRSN</a>) reported quarterly losses of $(0.19) per share which met the analyst consensus estimate. This is a 18.75 percent decrease over losses of $(0.16) per share from the same period last year.  The company reported quarterly sales of $2.75 million which missed the analyst consensus estimate of $5.84 million by 52.84 percent.  This is a 70.21 percent decrease over sales of $9.24 million the same period last year.</p>


MRSN

Mersana Therapeutics Q1 EPS $(0.19), Inline, Sales $2.75M Miss $5.84M Estimate

<p><figure class="table"><br />
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td colspan="3">Fiscal year 2026</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td colspan="3">The Company's fiscal year guidance is based on the following FY25 figures: Net sales: $674.5 billion, adjusted operating income1: $29.5 billion, and adjusted EPS1: $2.51.</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Consolidated metric</td>
<td>Original from 2.20.2025</td>
<td>As of 5.15.2025</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Net sales (cc)</td>
<td>
<p>Increase 3.0% to 4.0%</p>
<p>•Including approximately 20 bps headwind from lapping leap year</p>
<p>•Including approximately 20 bps tailwind from acquisition of VIZIO</p>
</td>
<td>Unchanged</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Adj. operating income (cc)</td>
<td>
<p>Increase 3.5% to 5.5%</p>
<p>•Including approximately 70 bps headwind from lapping leap year</p>
<p>•Including approximately 80 bps headwind from acquisition of VIZIO</p>
</td>
<td>Unchanged</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Interest, net</td>
<td>Increase approximately $100M to $200M</td>
<td>Unchanged</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Effective tax rate</td>
<td>Approximately 23.5% to 24.5%</td>
<td>Unchanged</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Non-controlling interest</td>
<td>Relatively flat</td>
<td>Unchanged</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Adjusted EPS</td>
<td>$2.50 to $2.60, including approximately $0.05 headwind from currency</td>
<td>Unchanged</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Capital expenditures</td>
<td>Approximately 3.0% to 3.5% of net sales</td>
<td>Unchanged</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
<p></p></figure></p>


Walmart Affirms FY2026 Adj EPS Guidance of $2.50-$2.60 vs $2.61 Est; Affirms FY2026 Sales Guidance of $694.74B-$701.48B vs $705.33B Est

<p>Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) reported quarterly losses of $(2.21) per share which missed the analyst consensus estimate of $(1.72) by 28.49 percent. This is a 531.43 percent decrease over losses of $(0.35) per share from the same period last year.  The company reported quarterly sales of $29.00 thousand which missed the analyst consensus estimate of $5.00 million by 99.42 percent.  This is a 99.84 percent decrease over sales of $17.58 million the same period last year.</p>


DTIL

Precision BioSciences Q1 EPS $(2.21) Misses $(1.72) Estimate, Sales $29.00K Miss $5.00M Estimate

GAMB

Gambling.com Gr Affirms FY2025 Sales Guidance of $170.00M-$174.00M vs $172.31M Est

<p>REE Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REE#NASDAQ">REE</a>) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(0.97) by 17.53 percent. This is a 74.6 percent increase over losses of $(3.15) per share from the same period last year.  The company reported $12.00 thousand in sales this quarter. This is a 97.36 percent decrease over sales of $455.00 thousand the same period last year.</p>


REE Automotive Q4 Adj. EPS $(0.80) Beats $(0.97) Estimate, Sales $12.00K Down From $455.00K YoY

<p>Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) reported quarterly losses of $(4.68) per share which missed the analyst consensus estimate of $(3.44) by 36.05 percent. This is a 81.28 percent increase over losses of $(25.00) per share from the same period last year.  The company reported quarterly sales of $640.92 thousand which missed the analyst consensus estimate of $2.35 million by 72.73 percent.  This is a 52.13 percent decrease over sales of $1.34 million the same period last year.</p>


WKHS

Workhorse Gr Q1 EPS $(4.68) Misses $(3.44) Estimate, Sales $640.92K.

<p>Marex Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRX#NASDAQ">MRX</a>) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.90 by 1.11 percent. This is a 31.88 percent increase over earnings of $0.69 per share from the same period last year.  The company reported quarterly sales of $467.30 million which beat the analyst consensus estimate of $458.60 million by 1.90 percent.  This is a 27.75 percent increase over sales of $365.80 million the same period last year.</p>


Marex Group Q1 Adj. EPS $0.91 Beats $0.90 Estimate, Sales $467.30M Beat $458.60M Estimate

Walmart Q1 US Comp Sales +4.5%

<p>American Shared Hospital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMS#AMEX">AMS</a>) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $0.04 by 350 percent. This is a 600 percent decrease over earnings of $0.02 per share from the same period last year.  The company reported quarterly sales of $6.11 million which missed the analyst consensus estimate of $8.63 million by 29.18 percent.  This is a 17.18 percent increase over sales of $5.22 million the same period last year.</p>


American Shared Hospital Q1 EPS $(0.10) Misses $0.04 Estimate, Sales $6.11M Miss $8.63M Estimate

BTDR

Bitdeer Technologies Q1 Adj. EPS $(0.39) Misses $(0.31) Estimate, Sales $70.13M Beat $66.77M Estimate

Walmart Q1 Global eCommerce Sales +22%

Gambling.com Gr Q1 Adj. EPS $0.32 Beats $0.25 Estimate, Sales $40.63M Beat $40.06M Estimate

<p>HC Wainwright &amp; Co.  analyst Matthew Caufield   reiterates Adverum Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) with a Buy and maintains $30 price target.</p>


Price Target

Reiteration

Analyst Ratings

ADVM

HC Wainwright & Co. Reiterates Buy on Adverum Biotechnologies, Maintains $30 Price Target

<p>Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.58 by 5.17 percent. This is a 1.67 percent increase over earnings of $0.60 per share from the same period last year.  The company reported quarterly sales of $165.61 billion which missed the analyst consensus estimate of $165.88 billion by 0.16 percent.  This is a 2.54 percent increase over sales of $161.51 billion the same period last year.</p>


Walmart Q1 Adj. EPS $0.61 Beats $0.58 Estimate, Sales $165.61B Miss $165.88B Estimate

<p>Lazydays Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) reported quarterly losses of $(0.09) per share. This is a 94.61 percent increase over losses of $(1.67) per share from the same period last year.  The company reported $165.80 million in sales this quarter. This is a 38.62 percent decrease over sales of $270.12 million the same period last year.</p>


Comments

N-able

Intérêt court

N-able (NYSE:NABL) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL